Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial
ContributorsVrieling, Conny; van Werkhoven, Erik; Maingon, Philippe; Poortmans, Philip; Weltens, Caroline; Fourquet, Alain; Schinagl, Dominic; Oei, Bing; Rodenhuis, Carla C; Horiot, Jean-Claude; Struikmans, Henk; Van Limbergen, Erik; Kirova, Youlia; Elkhuizen, Paula; Bongartz, Rudolf; Miralbell, Raymond; Morgan, David A L; Dubois, Jean-Bernard; Remouchamps, Vincent; Mirimanoff, René-Olivier; Hart, Guus; Collette, Sandra; Collette, Laurence; Bartelink, Harry
Published inJAMA Oncology, vol. 3, no. 1, p. 42-48
Publication date2017
Abstract
Keywords
- Adult
- Aftercare
- Breast Neoplasms/drug therapy/pathology/radiotherapy/surgery
- Carcinoma
- Intraductal
- Noninfiltrating/drug therapy/pathology/radiotherapy/surgery
- Female
- Follow-Up Studies
- Humans
- Mastectomy
- Segmental
- Middle Aged
- Neoplasm Invasiveness/pathology
- Neoplasm Recurrence
- Local/pathology
- Neoplasm Staging
- Prognosis
- Radiotherapy
- Adjuvant
Affiliation entities
Research groups
Citation (ISO format)
VRIELING, Conny et al. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial. In: JAMA Oncology, 2017, vol. 3, n° 1, p. 42–48. doi: 10.1001/jamaoncol.2016.3031
Main files (1)
Article (Published version)
Identifiers
- PID : unige:100678
- DOI : 10.1001/jamaoncol.2016.3031
- PMID : 27607734
Journal ISSN2374-2437
